InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,319.27
(
-0.04%
)
US TECH 100
18,243.60
(
0.06%
)
Dow Jones
39,860.96
(
-0.03%
)
Brent Oil
82.14
(
-0.38%
)
Bitcoin
69,857.60
(
-0.39%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12446
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Thursday, 02/03/2011 6:20:56 AM

Thursday, February 03, 2011 6:20:56 AM

Post# of 80490
This sums up big pharma, and our partner Merck real well:

http://www.minyanville.com/businessmarkets/articles/pfizer-merger-merck-merger-m2526a-stock/2/2/2011/id/32576?camp=syndication&medium=portals&from=yahoo

Bigger is not always better in the drug business. Pfizer increased its R&D spending 20% to $9.4 billion last year but has little to show for its efforts. There are no big, new products to replacing aging blockbusters.



I'll probably be skewered for saying this, but just think what Ariad could do with a research budget of $9.4 billion in one year..
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up